Blood & Plasma Components Market to be dominated by Growing Occurrences of Chronic Diseases and Surgeries through 2027
Growing prevalence of blood
disorders and rise in number of road accidents to drive the blood & plasma components
market in the forecast period, 2023-2027.
According to TechSci Research
report, “Blood & Plasma Components Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global blood &
plasma components market is anticipated to grow at a significant rate in the
forecast period, 2023-2027. The growing prevalence of trauma and road accidents,
rising volume of surgeries, and increase in number of people from chronic
conditions including cancer are the primary factors driving the demand for the global
blood & plasma components market. Growing technological advancements, increasing
investments for research and development activities, several blood donation
campaigns undertaken by various blood organizations, and rising
awareness associated with the significance of blood donations are expected to
influence the market demand. Also, the strategic initiatives such as
partnerships and product launches undertaken by the market players are also a
key factor for increasing the growth of the blood & plasma components
market, globally.
However, the rising risk of developing or
transferring an infection, lesser number of blood banks, and high costs of
blood plasma treatments may hamper the growth of the global blood & plasma
components market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Global
Blood & Plasma Components Market"
The global blood
& plasma components market is segmented into products, application, end
user and company.
Based on
products, the market is divided into packed red blood cells, platelets
products, frozen plasma, and plasma derived products. Based on plasma derived
products, the market is further divided into immunoglobulins, albumins,
coagulation factor concentrates, and others. The plasma derived products segment
is expected to hold the largest market share. This is attributed to the emerging
incidences of bleeding disorders such as Hemophilia A and B, and von Willebrand
disease.
Based on
application, the market is divided into hematology, solid tumor management, and
others. Based on hematology, the market is further divided into
hemoglobinopathy, hematologic malignancies treatment, coagulopathy, and others.
The hematology segment
is expected to witness largest market share. This is due to the technological
advancements, and product launches.
Based on end
user, the market is divided into hospitals & clinics, diagnostic
laboratories, and others. The hospitals & clinics segment is anticipated to
grow during the forecast period. This is attributed to the increase in chronic
diseases and cancer. Also, increase in technology and rise in number of private
hospitals with improved infrastructure are strengthening the growth of the
market.
Major
operating companies operating in global blood & plasma components market are:
·
CSL
Limited
·
Grifols
S.A.
·
ADMA
Biologics, Inc.
·
Takeda
Pharmaceutical Company Limited
·
Octapharma
AG
·
Kedrion
S.p.A
·
Emergent
BioSolutions Inc.
·
Bio
Products Laboratory Ltd.
·
LFB
S.A.
·
Versiti,
Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Asia-Pacific region
dominates the market in 2021 and is expected to maintain its dominance in the
coming years due to the existence of a high number of donors and rising
prevalence of hemophilia. The huge investment in R&D, constantly improving
healthcare infrastructure and facilities, favorable government initiatives, and
the improvement in patient awareness about plasma derivatives in the region are
another key factor. Also, numerous untapped prospects in the region are
expected to propel the global blood & plasma components market growth till 2027”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Blood & Plasma
Components Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2017-2027 Segmented By Products (Packed Red Blood Cells, Platelets
Products, Frozen Plasma, Plasma Derived Products), By Application (Hematology,
Solid Tumor Management, Others), By End User (Hospitals & Clinics,
Diagnostic Laboratories, Others), By company and By Region”, has evaluated the future
growth potential of global blood & plasma components market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global blood & plasma components market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com